Effects of Dance and Music Appreciation on Brain Health and Fitness in People at Risk for Alzheimer's Disease
NCT ID: NCT05507905
Last Updated: 2026-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2023-04-24
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Movement and Music Intervention for Individuals With Dementia
NCT03121950
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
NCT06496425
Musical Engagement of Brain LObes in Alzheimer's Disease Patients StudY
NCT05309369
Community Based Music and Dance Movement Therapy Group for Older Adults With Dementia
NCT03404050
Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment
NCT07105800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dance 3 Times Weekly (3xD)
Participants in this arm will attend classes 3 times a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Dance Classes
Four Different dance forms taught for 6 weeks each
Dance 2 Times Weekly (2xD)
Participants in this arm will attend classes 2 times a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Dance Classes
Four Different dance forms taught for 6 weeks each
Dance 1 Time Weekly (1xD)
Participants in this arm will attend a class 1 time a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Dance Classes
Four Different dance forms taught for 6 weeks each
Music Appreciation Classes (MAC)
In the MAC, the music associated with that dance form will be used as the subject for classes and will also change every 6 weeks.
Music
Music associated with dance forms in dance classes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Music
Music associated with dance forms in dance classes.
Dance Classes
Four Different dance forms taught for 6 weeks each
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Montreal Cognitive Assessment (MoCA) score ≥21
* Cognitively normal
* Low-active for past 6 months (\<30 min, 3 days/week of exercise, including walking for exercise)
* MRI compatible
* Willing and able to complete exercise testing.
* Has reliable transportation or is able to use transportation provided by the study.
* English speaking (needed for group class participation)
Exclusion Criteria
* Current diagnosis of a major neurological disorder (Alzheimer's disease, Lewy body dementia, Frontotemporal dementia, Parkinson's disease, amyotrophic lateral sclerosis, etc.)
* Unwilling or unable to provide consent for study participation.
* Currently symptomatic or cortical stroke or stroke deemed exclusionary by the study physician. Reported or observed evidence of strokes on MRI will be reviewed on a case-by-case basis by the study physician to assess factors such as location, size, time since stroke, and residual symptoms.
* Taking medication during the intervention times that could negatively influence safety
* Current cancer treatment or other major medical problems that might independently affect cognition or movement or interfere with ability to attend intervention or study visits.
* Chronic vertigo.
* Enrolled in another interventional research study ≤3 months prior to beginning this study.
* Hip fracture, hip or knee replacement, or spinal surgery in past 6 months.
* Health contraindications for completing a graded exercise test and movement intervention, including uncontrolled hypertension (BP\>200/110 mmHg), hypertriglyceridemia (TG\>400 mg/dl), uncontrolled diabetes (HbA1c \> 7.5), clinical evidence of anemia.
* Self-reports regularly drinking \> 14 alcoholic beverages a week or current illicit drug use.
* Unable or unwilling to understand study procedures and comply with them for the duration of the study.
62 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina Hugenschmidt, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00086190
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.